Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $463 | 4-6 weeks | 4-6 weeks | |
| 5 mg | $1,390 | 4-6 weeks | 4-6 weeks | |
| 10 mg | $2,230 | 4-6 weeks | 4-6 weeks |
| Description | Nesfrotamig is an immunoglobulin (H-γ1-scFv-L-κ) dimer humanized monoclonal antibody that targets human epidermal growth factor receptor 2 (ERBB2) and human tumor necrosis factor receptor superfamily member 9 (TNFRSF9). Nesfrotamig shows potential for use in ERBB2-positive tumor diseases, such as breast cancer and gastric cancer. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | ERBB2/TNFRSF9 |
| Cas No. | 2966936-23-0 |
| Storage | Store at low temperature -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.